Sarcoma Diagnosis and Treatment
Sarcoma Diagnosis and Treatment is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 61k research works in it since 1950. 10.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on research and treatment related to various types of sarcomas, including osteosarcoma, soft tissue sarcoma, Ewing's sarcoma, rhabdomyosarcoma, and synovial sarcoma. It covers topics such as chemotherapy, prognostic factors, genomic characterization, and the development of clinical practice guidelines for diagnosis and treatment. The papers also discuss the use of immunohistochemical markers for diagnostic purposes.
- Osteosarcoma
- Soft Tissue Sarcoma
- Ewing's Sarcoma
- Rhabdomyosarcoma
- Synovial Sarcoma
- Chemotherapy
- Prognostic Factors
- Genomic Characterization
- Clinical Practice Guidelines
- Immunohistochemical Marker
- Research works
- 61k fractional, since 1950
- In the world top 10%
- 6.3k per year above
- Top-10% rate
- 10.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +21% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Sarcoma Diagnosis and Treatment research?
By volume, the United States and China publish the most (2.3k and 1.5k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.3k works
- 2 China 1.5k works
- 3 India 974 works
- 4 Japan 617 works
- 5 Italy 411 works
- 6 Germany 357 works
- 7 United Kingdom 326 works
- 8 France 287 works
- 9 Türkiye 240 works
- 10 Spain 238 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Sarcoma Diagnosis and Treatment research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Sarcoma Diagnosis and Treatment research, followed by Memorial Sloan Kettering Cancer Center and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 81 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 67 works
- 3 All India Institute of Medical SciencesIndia 59 works
- 4 Peking UniversityChina 45 works
- 5 Sichuan UniversityChina 40 works
- 6 Massachusetts General HospitalUnited States 33 works
- 7 Mayo Clinic in ArizonaUnited States 32 works
- 8 Fondazione IRCCS Istituto Nazionale dei TumoriItaly 32 works
- 9 Harvard UniversityUnited States 31 works
- 10 Istituti di Ricovero e Cura a Carattere ScientificoItaly 30 works
Who are the leading researchers in Sarcoma Diagnosis and Treatment?
The most-cited researchers publishing on Sarcoma Diagnosis and Treatment include Matthew Meyerson.
- 1 Matthew Meyerson United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Sarcoma Diagnosis and Treatment research done?
The largest centres of Sarcoma Diagnosis and Treatment research in 2022–2025 are Beijing (China), New York (United States), Shanghai (China) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Oujda and Marrakesh.
Largest cities, 2022–2025
Where it is the local speciality
- OujdaMA · 21.5 works13×
- MarrakeshMA · 31.7 works8.5×
Location quotient: how much more of its research is in Sarcoma Diagnosis and Treatment than the world average.
Where is the best place to study Sarcoma Diagnosis and Treatment?
Among universities, judged by research, Institute of Cancer Research, All India Institute of Medical Sciences Bhubaneswar and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Institute of Cancer ResearchUnited Kingdom | 73.4 | 25.8% | 32.9× | 10 | +189.5% |
| 2 | All India Institute of Medical Sciences BhubaneswarIndia | 49.1 | 8.1% | 19.0× | 23 | — |
| 3 | All India Institute of Medical SciencesIndia | 48.1 | 1.0% | 10.0× | 59 | +23.3% |
| 4 | Indiana University – Purdue University IndianapolisUnited States | 47.8 | 20.8% | 4.6× | 14 | +103.9% |
| 5 | Indiana University School of Medicine?? | 47.8 | 19.2% | 5.7× | 9 | +149.3% |
| 6 | Heidelberg UniversityGermany | 45.5 | 22.8% | 3.4× | 17 | +10.9% |
| 7 | Medical University of GrazAustria | 44.4 | 12.9% | 8.4× | 10 | +16.1% |
| 8 | Medical College of WisconsinUnited States | 44.3 | 17.8% | 4.9× | 12 | +110.7% |
| 9 | University of PaduaItaly | 44.1 | 23.7% | 2.2× | 17 | +39.9% |
| 10 | Harvard UniversityUnited States | 43.9 | 18.9% | 2.5× | 31 | +11.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Sarcoma Diagnosis and Treatment research growing?
Output in 2018–2022 was 21% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Sarcoma Diagnosis and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.